(1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione

C30H45N3O6 — CID 59890419

IUPAC(1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
SMILESCc1nc2cc([C@@H]3C[C@@H]4O[C@]4(C)CCCC(C)[C@H](O)C(C)C(=O)C(C)(C)C(O)CC(=O)O3)ccc2n1CCN
InChIInChI=1S/C30H45N3O6/c1-17-8-7-11-30(6)25(39-30)15-23(20-9-10-22-21(14-20)32-19(3)33(22)13-12-31)38-26(35)16-24(34)29(4,5)28(37)18(2)27(17)36/h9-10,14,17-18,23-25,27,34,36H,7-8,11-13,15-16,31H2,1-6H3/t17?,18?,23-,24?,25-,27-,30+/m0/s1
InChIKeyOECWCCYOHZEYER-ZASXCBCNSA-N
MW543.71 g/mol
LogP3.60
Rot. Bonds3

About (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione

(1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione (PubChem CID 59890419) has the molecular formula C30H45N3O6 and a molecular weight of 543.71 g/mol. Its IUPAC name is (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione.

Molecular Properties

Compound Name(1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
PubChem CID59890419
Molecular FormulaC30H45N3O6
Molecular Weight543.71 g/mol
Exact Mass543.33
IUPAC Name(1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
SMILESCc1nc2cc([C@@H]3C[C@@H]4O[C@]4(C)CCCC(C)[C@H](O)C(C)C(=O)C(C)(C)C(O)CC(=O)O3)ccc2n1CCN
InChIInChI=1S/C30H45N3O6/c1-17-8-7-11-30(6)25(39-30)15-23(20-9-10-22-21(14-20)32-19(3)33(22)13-12-31)38-26(35)16-24(34)29(4,5)28(37)18(2)27(17)36/h9-10,14,17-18,23-25,27,34,36H,7-8,11-13,15-16,31H2,1-6H3/t17?,18?,23-,24?,25-,27-,30+/m0/s1
InChIKeyOECWCCYOHZEYER-ZASXCBCNSA-N
XLogP3.60
TPSA140.20 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500543.71
LogP ≤ 53.60
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione?
The IUPAC name of (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione (CID 59890419) is (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione.
What is the SMILES notation for (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione?
The canonical SMILES for (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione is Cc1nc2cc([C@@H]3C[C@@H]4O[C@]4(C)CCCC(C)[C@H](O)C(C)C(=O)C(C)(C)C(O)CC(=O)O3)ccc2n1CCN.
What is the InChIKey of (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione?
The InChIKey is OECWCCYOHZEYER-ZASXCBCNSA-N. The full InChI is InChI=1S/C30H45N3O6/c1-17-8-7-11-30(6)25(39-30)15-23(20-9-10-22-21(14-20)32-19(3)33(22)13-12-31)38-26(35)16-24(34)29(4,5)28(37)18(2)27(17)36/h9-10,14,17-18,23-25,27,34,36H,7-8,11-13,15-16,31H2,1-6H3/t17?,18?,23-,24?,25-,27-,30+/m0/s1.
What are the key properties of (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione?
(1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione has a molecular weight of 543.71 g/mol, XLogP of 3.60, 3 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,3S,11S,16R)-3-[1-(2-aminoethyl)-2-methylbenzimidazol-5-yl]-7,11-dihydroxy-8,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione is sourced from PubChem (CID 59890419), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).